Literature DB >> 10705872

Utility of c-erbB-2 expression in tissue and sera of ovarian cancer patients.

H Yazici1, K Dolapcioglu, F Buyru, N Dalay.   

Abstract

In this study, expression of the c-erbB-2 gene in tumors and healthy tissue of patients with ovarian cancer was investigated. Serum c-erbB-2 protein levels were also determined. Elevated serum values were observed in 45% of patients. c-erbB-2 protein levels in the tumors were significantly higher than in healthy tissue. Overexpression of the protein was observed in 60% of patients. However, no association was found between the clinical variables and tumor c-erbB-2 expression. This is the first study in the literature investigating the c-erbB-2 oncoprotein levels in the normal and tumor tissue. We conclude that the role of the c-erbB-2 gene in ovarian cancer warrants further studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10705872     DOI: 10.3109/07357900009038241

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  4 in total

1.  A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity.

Authors:  Yangbing Zhao; Qiong J Wang; Shicheng Yang; James N Kochenderfer; Zhili Zheng; Xiaosong Zhong; Michel Sadelain; Zelig Eshhar; Steven A Rosenberg; Richard A Morgan
Journal:  J Immunol       Date:  2009-11-01       Impact factor: 5.422

2.  High levels of global genome methylation in patients with retinoblastoma.

Authors:  Hülya Yazici; Hui-Chen Wu; Hulya Tigli; Elif Z Yilmaz; Rejin Kebudi; Regina M Santella
Journal:  Oncol Lett       Date:  2020-05-13       Impact factor: 2.967

3.  Role of HER-2/neu in Premalignant and Malignant Lesions of Uterine Cervix.

Authors:  Swasti Bajpai; Seema Awasthi; Shyamoli Dutta; Ankita Mittal; Ashutosh Kumar; Faiyaz Ahmad
Journal:  J Clin Diagn Res       Date:  2017-09-01

4.  A multiplex platform for the identification of ovarian cancer biomarkers.

Authors:  Kristin L M Boylan; Kate Geschwind; Joseph S Koopmeiners; Melissa A Geller; Timothy K Starr; Amy P N Skubitz
Journal:  Clin Proteomics       Date:  2017-10-10       Impact factor: 3.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.